万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 细胞形态:
上皮样
- 器官来源:
胃
- 生长状态:
贴壁生长
- 物种来源:
人
- 是否是肿瘤细胞:
1
- 库存:
大量
- 相关疾病:
胃癌
- 运输方式:
冻存运输
- ATCC Number:
CRL-5822™
| Designations: | NCI-N87 [N87] | ||
| Depositors: | J Park | ||
| Biosafety Level: | 1 | ||
| Shipped: | frozen | ||
| Medium & Serum: | See Propagation | ||
| Growth Properties: | adherent | ||
| Organism: | Homo sapiens | ||
| Morphology: | epithelial |
||
| Source: | Organ: stomach Disease: gastric carcinoma Derived from metastatic site: liver |
||
| Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. | ||
| Isolation: | Isolation date: 1976 | ||
| Receptors: | acetylcholine, muscarinic, expressed [23078 ] | ||
| Tumorigenic: | Yes | ||
| Oncogene: | myc +; erb B2 + | ||
| DNA Profile (STR): | Amelogenin: X,Y CSF1PO: 8,12 D13S317: 8,11 D16S539: 9,13 D5S818: 12,13 D7S820: 10,11 THO1: 9 TPOX: 9,11 vWA: 15,16 |
||
| Cytogenetic Analysis: | near diploid; DM were present in 64% of cells examined | ||
| Gender: | male | ||
| Comments: | NCI-N87 cells express the surface glycoproteins carcinoembryonic antigen (CEA) and TAG 72, and are L-dopa decarboxylase (DDC) negative. They were minimally positive for vasoactive intestinal peptide (VIP) receptors and lacked gastrin receptors. They were fiound to express receptors for muscarinic cholinergic agents. No evidence of amplification or rearrangements was noted with the N-myc, L-myc, myb and EGF receptor genes. The cell line expressed levels of c-myc and c-erb-B 2 RNA that were comparable to other cell lines.There was no expression of the following genes: N-myc, L-myc, c-cis, IGF-2, or gastrin releasing peptide. NCI-N87 cells have a reported plating efficiency of 4.3%. | ||
| Propagation: | ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Atmosphere: air, 95%; carbon dioxide (CO2), 5% Temperature: 37.0°C Growth Conditions: They grow as an adherent monolayer of tightly knit epithelial cells. |
||
| Subculturing: | Protocol:
Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:4 is recommended Medium Renewal: Two to three times weekly |
||
| Preservation: | Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO Storage temperature: liquid nitrogen vapor phase |
||
| Doubling Time: | 47 hrs | ||
| Related Products: | Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001 recommended serum:ATCC 30-2020 |
||
| References: | 23078: Park JG, et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 50: 2773-2780, 1990. PubMed: 2158397 23570: . NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.. |
||
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验都是贴壁细胞,在消化传代过程中,步骤如下:倒尽旧的培养液->用无血清的培养基清洗一两次->加入一定量的胰酶,置于37度培养箱中5--10分钟,使细胞悬浮->显微镜下观察,待细胞大部分变圆时,回到超静台->加入一定量的含血清的新培养液,以终止胰酶作用->反复吹打细胞->再置显微镜下观察,直到细胞全部悬浮起来->吸出一部分加入新的培养瓶中->最后再补充加入一定量新的培养液。注意: 1、吹细胞时尽量多吹边角儿,此处细胞生长的多。2、吸出细胞前要混匀,可以剧烈震荡培养瓶。3、我们用的是DMEM
Science 子刊揭露遗传性肺癌亚型,我们离肺癌精准医疗还有多远?
Medicine 2021 年 1 月 27 号,来自美国国家癌症研究所(NCI)的 Anish Thomas 教授带领团队在 Science 子刊 Science Translational Medicine 上发表了题为 Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair–targeted therapies 的研究
一、实验材料NCI-H1299,购自上海晶莱生物技术有限公司。表 2.1.1 主要试剂试剂与耗材厂家(货号)细胞培养瓶FALCON 中国(353014)Penicillin/streptomycin solution(KGY002)0.25% Tripsin-EDTA(BK-E3076)PBS(BK330-2)胎牛血清GIBCO 美国(10270-106)1640 培养基Hyclone 美国(SH3080901)Annexin V-FITC/PI 凋亡试剂盒 二、实验仪器表 2.2.1 主要
技术资料暂无技术资料 索取技术资料







